Shandong Xinhua Pharmaceutical (00719.HK) subsidiary obtains drug registration certificate for donepezil hydrochloride orally disintegrating tablets

Zhito Finance APP News: Shandong Xinhua Pharmaceutical (00719.HK) has issued an announcement that recently, Shandong Zibo Xinda Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinda Pharmaceutical"), a wholly-owned subsidiary of Shandong Xinhua Pharmaceutical Co., Ltd., received the "Drug Registration Certificate" for Donepezil Hydrochloride Orally Disintegrating Tablets (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration.